Karyopharm Therapeut
(KPTI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,570 | -37,362 | -143,099 | -101,262 | -66,756 |
| Depreciation Amortization | 200 | -618 | -2,754 | -2,027 | -1,376 |
| Accounts receivable | -11,033 | -4,120 | 20,124 | 9,163 | 14,806 |
| Accounts payable and accrued liabilities | -326 | 1,905 | 350 | -1,830 | -486 |
| Other Working Capital | -20,189 | -10,715 | 31,421 | 12,624 | 12,075 |
| Other Operating Activity | -37,305 | 7,185 | 1,235 | 9,194 | -2,871 |
| Operating Cash Flow | $-82,223 | $-43,725 | $-92,723 | $-74,138 | $-44,608 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -195 | -195 | N/A | N/A | N/A |
| Purchase Of Investment | -36,511 | -31,608 | -159,151 | -142,591 | -96,526 |
| Sale Of Investment | 109,908 | 53,743 | 167,091 | 123,688 | 85,308 |
| Investing Cash Flow | $73,202 | $21,940 | $7,940 | $-18,903 | $-11,218 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 83,300 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 772 | N/A | 1,124 | 860 | 860 |
| Other Financing Activity | -43,106 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $40,966 | $N/A | $1,124 | $860 | $860 |
| Exchange Rate Effect | -27 | -16 | -34 | -123 | -71 |
| Beginning Cash Position | 53,192 | 53,192 | 136,885 | 136,885 | 136,885 |
| End Cash Position | 85,110 | 31,391 | 53,192 | 44,581 | 81,848 |
| Net Cash Flow | $31,918 | $-21,801 | $-83,693 | $-92,304 | $-55,037 |
| Free Cash Flow | |||||
| Operating Cash Flow | -82,223 | -43,725 | -92,723 | -74,138 | -44,608 |
| Capital Expenditure | -195 | -195 | N/A | N/A | N/A |
| Free Cash Flow | -82,418 | -43,920 | -92,723 | -74,138 | -44,608 |